Business Description
Cyclezyme AB
ISIN : SE0020975852
Total Employee Number:
3Compare
Compare
Traded in other countries / regions
CYCLE.Sweden IPO Date
2023-12-22Description
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.02 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 33.2 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -4.8 | |||||
3-Year EPS without NRI Growth Rate | -7.2 | |||||
3-Year FCF Growth Rate | -58.6 | |||||
3-Year Book Growth Rate | 57 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.58 | |||||
9-Day RSI | 54.37 | |||||
14-Day RSI | 56.37 | |||||
3-1 Month Momentum % | 38.13 | |||||
6-1 Month Momentum % | 28.62 | |||||
12-1 Month Momentum % | 9.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.45 | |||||
Quick Ratio | 2.45 | |||||
Cash Ratio | 2.06 | |||||
Days Sales Outstanding | 183.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.6 | |||||
Shareholder Yield % | -4.31 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 367.29 | |||||
Operating Margin % | -292.62 | |||||
Net Margin % | -297.25 | |||||
EBITDA Margin % | -284.23 | |||||
FCF Margin % | -579.45 | |||||
OCF Margin % | -264.69 | |||||
ROE % | -32.36 | |||||
ROA % | -27.77 | |||||
ROIC % | -37.46 | |||||
3-Year ROIIC % | -6.62 | |||||
ROC (Joel Greenblatt) % | -913.5 | |||||
ROCE % | -30.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 89.52 | |||||
PB Ratio | 8.95 | |||||
Price-to-Tangible-Book | 45.96 | |||||
EV-to-EBIT | -29.94 | |||||
EV-to-EBITDA | -30.74 | |||||
EV-to-Revenue | 87.39 | |||||
EV-to-FCF | -15.4 | |||||
| Price-to-Net-Current-Asset-Value | 55.58 | |||||
| Price-to-Net-Cash | 82.41 | |||||
Earnings Yield (Greenblatt) % | -3.34 | |||||
FCF Yield % | -6.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cyclezyme AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 0.691 | ||
| EPS (TTM) (kr) | -0.822 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 81.12 | ||
| 14-Day RSI | 56.37 | ||
| 14-Day ATR (kr) | 2.777201 | ||
| 20-Day SMA (kr) | 23.0475 | ||
| 12-1 Month Momentum % | 9.57 | ||
| 52-Week Range (kr) | 10.3 - 30.3 | ||
| Shares Outstanding (Mil) | 2.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cyclezyme AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cyclezyme AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 122 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 45 days | ||
| General meeting for 2026 | 2026-05-22 10:30 | 15.35 (+18.08%) | ||
| First quarter earnings results for 2026 | 2026-05-22 | 15.35 (+18.08%) | ||
| Annual report for 2025 | 2026-04-29 | 14.20 (+1.43%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 14.65 (-0.34%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 17.80 (+0.28%) | ||
| Second quarter earnings results for 2025 | 2025-08-29 | 27.50 (+4.96%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 14.65 (-11.21%) | ||
| General meeting for 2025 | 2025-05-15 | 14.65 (-11.21%) |
Show
Entries
Cyclezyme AB Frequently Asked Questions
What is Cyclezyme AB(XSAT:CYCLE)'s stock price today?
The current price of XSAT:CYCLE is kr23.90. The 52 week high of XSAT:CYCLE is kr30.30 and 52 week low is kr10.30.
When is next earnings date of Cyclezyme AB(XSAT:CYCLE)?
The next earnings date of Cyclezyme AB(XSAT:CYCLE) is 2026-08-28.
Does Cyclezyme AB(XSAT:CYCLE) pay dividends? If so, how much?
Cyclezyme AB(XSAT:CYCLE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Cyclezyme AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers